IL140890A0 - Adjuvant and vaccine compositions containing monophosphoryl lipid a - Google Patents

Adjuvant and vaccine compositions containing monophosphoryl lipid a

Info

Publication number
IL140890A0
IL140890A0 IL14089099A IL14089099A IL140890A0 IL 140890 A0 IL140890 A0 IL 140890A0 IL 14089099 A IL14089099 A IL 14089099A IL 14089099 A IL14089099 A IL 14089099A IL 140890 A0 IL140890 A0 IL 140890A0
Authority
IL
Israel
Prior art keywords
adjuvant
vaccine compositions
monophosphoryl lipid
compositions containing
containing monophosphoryl
Prior art date
Application number
IL14089099A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL140890A0 publication Critical patent/IL140890A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IL14089099A 1998-07-14 1999-07-13 Adjuvant and vaccine compositions containing monophosphoryl lipid a IL140890A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11539298A 1998-07-14 1998-07-14
PCT/US1999/015942 WO2000003744A2 (fr) 1998-07-14 1999-07-13 Compositions d'adjuvants et de vaccins contenant un lipide monophosphoryle a

Publications (1)

Publication Number Publication Date
IL140890A0 true IL140890A0 (en) 2002-02-10

Family

ID=22361090

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14089099A IL140890A0 (en) 1998-07-14 1999-07-13 Adjuvant and vaccine compositions containing monophosphoryl lipid a

Country Status (14)

Country Link
EP (1) EP1096954B1 (fr)
JP (1) JP2002520373A (fr)
KR (1) KR100586804B1 (fr)
CN (1) CN1247262C (fr)
AT (1) ATE278420T1 (fr)
AU (1) AU763770B2 (fr)
BR (1) BR9912067A (fr)
CA (1) CA2333578C (fr)
DE (1) DE69920915T2 (fr)
DK (1) DK1096954T3 (fr)
ES (1) ES2229745T3 (fr)
IL (1) IL140890A0 (fr)
PT (1) PT1096954E (fr)
WO (1) WO2000003744A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
EP1141308B1 (fr) 1998-12-22 2007-02-07 Microscience Limited Genes et proteines de streptococcus du groupe b, et leur utilisation
PL206832B1 (pl) * 2000-05-19 2010-09-30 Corixa Corp Zastosowanie związków opartych na mono- i disacharydach
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
EA014314B1 (ru) * 2005-08-02 2010-10-29 Новартис Вэксинес Энд Дайэгностикс Срл Пониженная интерференция между маслосодержащими адъювантами и антигенами, содержащими поверхностно-активные вещества
AU2012279154A1 (en) * 2011-07-01 2014-02-20 The Regents Of The University Of California Herpes virus vaccine and methods of use
US9241988B2 (en) 2012-04-12 2016-01-26 Avanti Polar Lipids, Inc. Disaccharide synthetic lipid compounds and uses thereof
US20160193326A1 (en) * 2013-09-05 2016-07-07 Immune Design Corp. Vaccine Compositions for Drug Addiction
CN116199727A (zh) * 2021-12-01 2023-06-02 上海安奕康生物科技有限公司 一种mpl三乙胺盐、其制备工艺及应用
WO2023212702A2 (fr) * 2022-04-28 2023-11-02 Kansas State University Research Foundation Enfermement de colloïdes peptidiques amphipathiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672496B3 (fr) * 1990-07-18 1993-05-28 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
ES2109685T5 (es) * 1993-03-23 2005-09-01 Smithkline Beecham Biologicals S.A. Composiciones para vacunas que contienen monofosforil-lipido a 3-o-desacilado.
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
GB9612137D0 (en) * 1996-06-10 1996-08-14 Quaker Oats Co Treatment of dried fruit
CN1150001C (zh) * 1996-07-03 2004-05-19 卫材株式会社 含有脂质a类似物的注射剂及其制备方法

Also Published As

Publication number Publication date
AU763770B2 (en) 2003-07-31
KR100586804B1 (ko) 2006-06-07
PT1096954E (pt) 2004-12-31
CN1307483A (zh) 2001-08-08
DK1096954T3 (da) 2005-01-31
DE69920915D1 (de) 2004-11-11
DE69920915T2 (de) 2006-02-16
ES2229745T3 (es) 2005-04-16
CA2333578C (fr) 2010-11-16
ATE278420T1 (de) 2004-10-15
AU5101899A (en) 2000-02-07
WO2000003744A2 (fr) 2000-01-27
EP1096954A2 (fr) 2001-05-09
CA2333578A1 (fr) 2000-01-27
JP2002520373A (ja) 2002-07-09
BR9912067A (pt) 2001-04-10
EP1096954B1 (fr) 2004-10-06
CN1247262C (zh) 2006-03-29
WO2000003744A3 (fr) 2000-04-27
KR20010071637A (ko) 2001-07-28

Similar Documents

Publication Publication Date Title
WO1999040936A3 (fr) Vaccins pneumococciques ou meningococciques formules avec l'interleukine-12
GB9725084D0 (en) Vaccine compositions
WO2003039330A3 (fr) Appareils permettant de corriger et de traiter des deformations de la colonne vertebrale et techniques correspondants
NZ508110A (en) Attenuated mutants of salmonella which constitutively express the Vi antigen
IL140890A0 (en) Adjuvant and vaccine compositions containing monophosphoryl lipid a
NZ513202A (en) Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde
CA2177667A1 (fr) Compositions de vaccin pour mammiferes comprenant un adjuvant constitue de squalene ou de squalane, lecithine et un ester polyoxyethylene sorbitan
DE69524742D1 (de) Interleukin-11 präparat
AU2230199A (en) Vaccine compositions and methods of modulating immune responses
WO2003059916A8 (fr) Procedes de preparation d'alkyl diarylborinates et d'acides diarylboroniques complexes
DE69634024D1 (de) Adjuvans für vitale Impfstoffe
WO2000025815A8 (fr) Nouveaux immunoadjuvants
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
AU4596397A (en) Rotavirus vaccine formulations
WO1999027892A3 (fr) Preparations stables au stockage, a polymerisation par voie cationique, presentant un meilleur comportement en cuisson
WO2000033887A3 (fr) Procedes et formulations permettant de reduire des anticorps circulants
AU2501795A (en) Branched polysaccharide, microorganism producing it and compositions containing them
BG100248A (en) Squalene synthetase inhibitors
AU6849198A (en) Neurotrypsin
TW365519B (en) Egg yolk phospholipid composition
BG105372A (en) Immunogenic liposome compositions
CA2442698A1 (fr) Liposome thermolabile a temperature de liberation regulee
AU3315200A (en) 1,5-anhydro-d-fructose substituted with a hydrophobic group for use as anti-oxidant and/or emulsifier
WO1999016466A3 (fr) Compositions de vaccin et procedes servant a augmenter l'efficacite d'un vaccin
AU5338199A (en) Methods and compositions for inhibiting or stimulating telomerase assembly

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees